Guidance For The Submission Of The South African CTD-eCTD – General & Module

This document has been archived.

This guideline is intended to provide recommendations to applicants wishing to submit applications for the registration of medicines. It represents the South African Health Product Regulatory Authority’s (SAHPRA) current thinking on the safety, quality and efficacy of medicines. It is not intended as an exclusive approach. SAHPRA reserves the right to request any additional information to establish the safety, quality and efficacy of a medicine in keeping with the knowledge current at the time of evaluation. Alternative approaches may be used but these should be scientifically and technically justified. SAHPRA is committed to ensuring that all registered medicines will be of the required quality, safety and efficacy. It is important that applicants adhere to the administrative requirements to avoid delays in the processing and evaluation of applications.

Guidelines and application forms are available from the office of the CEO and the website